New Strategies for Cancer Immunotherapy
Webinar

New Strategies for Cancer Immunotherapy

An expert panel will discuss the interplay between cancer and the immune system, and how researchers develop immunotherapies and other immune-supporting strategies against cancer. 

Share

 LIVE Symposium

Monday, October 23, 2023
1:00 - 4:00 PM Eastern Time

The immune system plays a large role in a body’s fight against cancer, but tumors can avoid the immune response. Scientists work to restore anti-cancer immune activity by augmenting existing immune mechanisms and circumventing tumor immune-evasion strategies.

In this virtual symposium brought to you by The Scientist, an expert panel will examine immunotherapies and other immune-supporting strategies that help prevent, control, and eliminate cancer.

Symposium program

1:00 PM – Introduction

1:10 PM – Mapping Out Immune Cells in Cancer Using Spatially Resolved Transcriptomics

Joakim Lundeberg, PhD

1:45 PM – Mass Spectrometry Approaches for Identifying Immunotherapeutic Targets in Cancer: Not Just Scratching the Surface

Arun Wiita, PhD

2:20 PM – Leveraging the Tumor-Stroma-Immune Interface to Improve B-T Cell Crosstalk in Tertiary Lymphoid Structures

Tallia Bruno, PhD 

 2:55 PM – Tumor-derived Immune Dysfunction Spreading to the Lymph Node

Ed Roberts, PhD

3:20 PM - Open panel Q&A session
Nathan Ni from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.

Joakim Lundeberg, PhD

Joakim Lundeberg, PhD
Science for Life Laboratory
KTH Royal Institute of Technology

Arun

Arun Wiita, MD, PhD
Associate Professor
Department of Laboratory Medicine
Department of Bioengineering and Therapeutic Sciences
University of California, San Francisco


Tullia C. Bruno, PhD

Tullia C. Bruno, PhD
Assistant Professor
Tumor Microenvironment Center
Cancer Immunology and Immunotherapy Program
UPMC Hillman Cancer Center
Department of Immunology
University of Pittsburgh School of Medicine


Ed Roberts

Ed Roberts, PhD
Group Leader
School of Cancer Sciences
CRUK Scotland Institute and University of Glasgow


 


Top Image Credit:

New Strategies for Cancer Immunotherapy

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies